9-Fluoro-2,3-Dihydro-10-(4-Methyl-1-Piperazinyl)-7-Oxo-7H-Pyrido(1,2,3-de)-1,4-Benzothiazine-6-Carboxylic Acid 1-Oxide Monohydrochlo ride
CAS: 132843-25-5
Ref. 3D-FF103798
Undefined size | To inquire |
Product Information
- 9-Fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzothiazine-6-carboxylic acid 1-oxide, monohydrochloride
- Rufloxacinsulfoxide
- 7H-Pyrido(1,2,3-de)-1,4-benzothiazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-, 1-oxide, monohydrochloride
- 9-fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid 1-oxide hydrochloride (1:1)
9-Fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7H--pyrido(1,2,3-de)-1,4-benzothiazine--6--carboxylic acid 1 oxide monohydrochloride (9FDA) is a drug that has been used in pharmacokinetic studies in humans. It is administered as a single intravenous injection and has a half life of 12 hours. 9FDA is metabolized to 9FDAA and 9FDBA by the liver. The most abundant metabolites are found in urine after intravenous injections. The pharmacokinetics of this drug have been studied using high performance liquid chromatography with acetonitrile as the mobile phase. Constants were measured by injecting rhesus monkeys with 9FDA and measuring plasma concentrations over time using high performance liquid chromatography with an acetonitrile gradient
Chemical properties
Technical inquiry about: 3D-FF103798 9-Fluoro-2,3-Dihydro-10-(4-Methyl-1-Piperazinyl)-7-Oxo-7H-Pyrido(1,2,3-de)-1,4-Benzothiazine-6-Carboxylic Acid 1-Oxide Monohydrochlo ride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.